Introduction {#Sec1}
============

In 2009, the Centers for Medicare and Medicaid Services (CMS) established the Electronic Health Records Incentive Programs "to promote the adoption and meaningful use of interoperable health information technology (HIT) and qualified electronic health records (EHRs)" \[[@CR1]\]. One HIT approach for achieving this goal is sharing information in the EHR with patients via web portals. The advantages of providing patients with access to their test results are numerous, including fostering self-efficacy and patient activation as well as preventing test results from falling-through-the cracks, which is a common medical error and a threat to patient safety \[[@CR2]\]. For this reason, the Joint Commission established goals for communicating test results \[[@CR3]\]. Patient portals, like *MyChart* from *Epic,* is one method patients can access their test results. Patient web portals have been shown to improve patient satisfaction and health care quality \[[@CR4]--[@CR10]\].

A commonly performed test among older adults is dual energy x-ray absorptiometry (DXA), which is the standard screening tool for identifying patients at increased risk for hip or other fragility fractures. But even when a diagnosis of osteoporosis is made from the DXA, patients do not always receive appropriate pharmacotherapy consistent with treatment guidelines \[[@CR11]\]. Indeed, one study found that two-thirds of patients with DXA results indicating osteoporosis did not receive appropriate pharmacotherapy. And using chart review methods, another study revealed among 23% of abnormal DXA results there was no evidence that the patient's clinician had reviewed their DXA results or communicated them to their patients \[[@CR11]\]. One way to increase patient access to their DXA results would be to use web portals to communicate test results directly to patients. To our knowledge, however, there have not been any studies of patients' use of web portals for learning about their DXA results. Sharing DXA results with patients via web portals may also activate them to follow-up with their health care provider, especially if their results are abnormal.

Web portals are relatively new in medicine. A recent systematic review found low use rates for patient web portals across a number of studies \[[@CR12]\]. The main reasons given included concerns about confidentiality, poor awareness of web portals, and inadequate user friendliness. Overall, patients who did use web portals as part of the health care were typically younger, and more likely to be White, affluent, women with chronic disease \[[@CR12]\].

Our objective was to examine patient and clinical factors associated with the use of web portals to review their DXA results. We did this using data from the Patient Activation after DXA Result Notification clinical trial (PAADRN- <https://clinicaltrials.gov/ct2/show/NCT01507662>), Identifying the characteristics of web portal users, specifically for DXA results, may provide the information needed to inform practitioners about the appropriate ways to communicate DXA results, as well as provide insight into how best to craft interventions to increase web portal use.

Methods {#Sec2}
=======

PAADRN study {#Sec3}
------------

This manuscript describes a secondary data analysis of data from the PAADRN study, a pragmatic, randomized controlled trial conducted at the DXA clinics of three medical centers in the United States (U.S.)---the University of Iowa (UI), the University of Alabama at Birmingham (UAB), and Kaiser Permanente of Georgia (KPGA) \[[@CR13]\]. PAADRN's main purpose was to examine the effects a tailored DXA result notification letter accompanied by a bone-health educational brochure mailed to patients on guideline-concordant osteoporosis pharmacotherapy., Eligible patients were those presenting for DXA who were 50 years old or older and could read and speak English. We excluded patients who had significant cognitive impairments which would prevent them from providing informed consent, prisoners, and those with visual or hearing impairments. Institutional Review Boards from all three sites approved the study and we collected written or verbal informed consent per institutional policy.

Survey instrument {#Sec4}
-----------------

As previously described \[[@CR13]\], study-specific RAs asked participants questions about their demographics, bone and general health histories, health literacy, subjective numeracy (α = 0.811) \[[@CR14]\], preference for self-care (α = 0.771) \[[@CR15]\], patient activation (PAM, α = 0.661) \[[@CR16]\], and measures of their osteoporosis-related knowledge (α = 0.685) \[[@CR17], [@CR18]\], health beliefs (α = 0.737) \[[@CR19]\], and self-efficacy (α = 0.958) \[[@CR20]\]. About 12-weeks later, trained interviewers from the Iowa Social Science Research Center re-contacted patients by telephone and asked them a series of questions related to their DXA. In particular, patients were asked if they knew their DXA results, and if they did, how it was that they came to know about their DXA results. Patients could select more than one response option. The response options for this latter question were: meeting with their provider in persontalking to their provider over the phoneexchanging emails with their providerreceiving a mailed letter with their results (a letter was mailed to all intervention participants)seeing their results on an electronic medical record or portalgetting their results from the DXA technicianor by some other means.

Once participants identified the methods by which they received their DXA results, the interviewers then asked them to indicate the order in which they received the results (e.g. which method was the first, second, third, etc., by which you learned of your results). A more detailed description of the interview protocol is available elsewhere \[[@CR13]\].

Analytic sample {#Sec5}
---------------

We limited the current analysis to PAADRN participants from UI and KPGA because both sites had web portals available at the time of PAADRN enrollment. UAB did not have a web portal for the entire study period, and thus UAB patients were excluded. Web portal assignment was not randomized in this study. Both UI (since June 2010) and KPGA (since 2005) offered patients access to *Epic's* (Verona, WI) web portal (known as *MyHealthManager* for KPGA and *MyChart* for UI). Of the 3185 UI patients who were potentially eligible for PAADRN, administrative records indicated that 62.6% had activated their *MyChart* accounts. Similarly, of 15,642 potentially eligible patients at KPGA, administrative records indicated that 65% had activated their *MyHealthManager* accounts. We further limited the analytic sample to PAADRN participants who reported knowing what their test results were at the time of their 12-week survey.

Statistical analysis {#Sec6}
--------------------

We first used bivariable analysis to compare all web portal users with all non-web portal users. This included a comparison of demographic characteristics (clinical site, age, sex, race: white vs. not white, and education), patient health beliefs (health literacy, numeracy, patient activation, preference for self-care \[[@CR14]\]), health characteristics (self-reported history of low bone density or osteoporosis, self-rated health, and a number of additional chronic conditions), DXA ordering provider characteristics (intervention assignment, provider's gender, and whether the provider was the same sex as the patient). Continuous variables (age, health literacy, numeracy, patient activation scores, and self-care preferences) were categorized and some categorical variables (race, education, number of chronic conditions) were collapsed to improve interpretation.

Next, among web portal users we distinguished between three groups. The first group of web portal users included those who reported only learning about their results from the web portal. The second group included those who used the web portal as their first method to learn of their results, but also learned about their results later on from another source. The third group included those who first learned about their results from another method, but also learned about their results subsequently from the web portal. We compared these three groups on the demographic characteristics, patient health beliefs, health, and provider characteristics to determine whether pooling these groups was appropriate.

Finally, we used multivariable logistic regression with any web portal use as the outcome, and all of the predictors that were used in the bivariable analyses. Adjusted odds ratios (AORs) and 95% CIs were calculated for each predictor. Case-wise deletion was used to address missing data. To examine the heterogeneity of treatment effects (HTEs) involving study site, we conducted sensitivity analyses by including interactions of site vs. all of the other predictors one at a time in the adjusted models. All analyses were performed using SAS 9.4, Cary, NC.

Results {#Sec7}
=======

Study population {#Sec8}
----------------

PAADRN's CONSORT flow chart and descriptive baseline data for all 7749 participants can be found elsewhere \[[@CR21]\]. Of the 4669 patients enrolled at UI and KPGA, 4005 (85.8%) completed the 12-week interview, and 84.9% of those (*N* = 3399) knew the results of their DXA (Table [1](#Tab1){ref-type="table"}). Overall, 13.9% (*n* = 649) of participants used the web portal to view their DXA results. Table 1Characteristics of those viewing DXA results via web portal vs. those not viewing DXA results via web portal among patients reported knowing their DXA results (*N* = 3399)CharacteristicViewed DXA results via web portal,\
N (%) = 649 (19.1%)Did not view DXA results via web portal\
N (%) =2750 (80.9%)*P*-valueDemographics Site  UI385 (29.26%)931 (70.74%)\< 0.001  KPGA264 (12.67%)1819 (87.33%) Age  Mean (SD)64.4 (7.4)66.5 (8.1)\< 0.001   \< 65313 (22.66%)1068 (77.34%)\< 0.001  65--74270 (18.38%)1199 (81.62%)   \> 7566 (12.02%)483 (87.98%) Gender of patient  Male113 (17.15%)546 (82.85%)0.157  Female536 (19.56%)2204 (80.44%) Race  White570 (21.19%)2120 (78.81%)\< 0.001  Non-white79 (11.14%)630 (88.86%) Education  High school or less88 (10.92%)718 (89.08%)\< 0.001  Some college197 (18.02%)896 (81.98%)  Completed college157 (21.3%)580 (78.7%)  Graduate school204 (27.79%)530 (72.21%)Patient health personal characteristics Health Literacy  Low54 (12.08%)393 (87.92%)\< 0.001  High592 (20.27%)2328 (79.73%) Subjective Numeracy  Low160 (13.86%)994 (86.14%)\< 0.001  Medium213 (18.85%)917 (81.15%)  High273 (25.11%)814 (74.89%) Patient Activation Score  Level 1 (0--42.5)50 (15.2%)279 (84.8%)0.003  Level 2 (47.4--52.9)100 (16.05%)523 (83.95%)  Level 3 (56.4--66.0)302 (19.28%)1264 (80.72%)  Level 4 (68.5--100)194 (22.61%)664 (77.39%) Krantz Information Scale  Low164 (14.84%)941 (85.16%)\< 0.001  Medium236 (20.36%)923 (79.64%)  High246 (22.18%)863 (77.82%) Krantz Behavioral Scale  Low187 (15.7%)1004 (84.3%)\< 0.001  Medium193 (18.16%)870 (81.84%)  High261 (23.66%)842 (76.34%)Participant health characteristics History of Osteoporosis  Normal320 (16.04%)1675 (83.96%)\< 0.001  Osteopenia206 (26.68%)566 (73.32%)  Osteoporosis123 (19.46%)509 (80.54%) Self-rated Health  Poor17 (17.17%)82 (82.83%)0.007  Fair68 (15.96%)358 (84.04%)  Good215 (17.68%)1001 (82.32%)  Very good245 (19.84%)990 (80.16%)  Excellent104 (24.94%)313 (75.06%)Number of Chronic Conditions  None305 (19.28%)1277 (80.72%)0.485 1--2313 (19.31%)1308 (80.69%)  \> 231 (15.82%)165 (84.18%)Provider characteristics Intervention  Intervention316 (17.86%)1453 (82.14%)0.057  Usual care333 (20.43%)1297 (79.57%) Patient Provider's Gender  Male208 (16.72%)1036 (83.28%)0.007  Female441 (20.46%)1714 (79.54%) Gender of patient and provider  Female providers and female patients398 (21.37%)1464 (78.63%)0.001  Female providers and male patients43 (14.68%)250 (85.32%)  Male providers and male patients70 (19.13%)296 (80.87%)  Male providers and female patients138 (15.72%)740 (84.28%)

Unadjusted associations with web portal use {#Sec9}
-------------------------------------------

Participants who knew their DXA results and reported using the web portal as one method of viewing their results were more likely to be from UI, younger, White, more highly educated, have higher health literacy and numeracy, have higher patient activation scores, have higher health information-seeking preferences. Additionally, web portal users differed on health-related characteristics such as those with history of osteopenia or osteoporosis, better self-rated health, and a female provider or a provider of the same gender than participants who did not use the web portal to view their DXA results (Table [1](#Tab1){ref-type="table"}).

Method of learning of DXA result {#Sec10}
--------------------------------

Of the 649 participants who used the web portal, 192 (29.6%) learned of their DXA results only through the web portal, 230 (35.4%) learned of their DXA results by another method as well but through the web portal first, and 227 (35.0%) learned of their DXA results from another method first but viewed the result later via the web portal (Table [2](#Tab2){ref-type="table"}). The three groups did not differ statistically on any characteristic; thus, it was appropriate for us to combine all three groups into one 'web portal use' group. Table 2Characteristics of web portal users who first learned their DXA results through different sources (*N* = 649)CharacteristicWeb portal only,\
N (%) = 192 (29.6%)Web portal first,\
N (%) = 230 (35.4%)Web portal, but not first method reported, N (%) = 227 (35.0%)*P*-valueDemographics Site  UI117 (30.39%)132 (34.29%)136 (35.32%)0.742  KPGA75 (28.41%)98 (37.12%)91 (34.47%) Age  Mean (SD)64.9 (8.2)64.1 (7.1)64.3 (7.2)0.503   \< 6591 (29.07%)113 (36.1%)109 (34.82%)0.290  65--7474 (27.41%)99 (36.67%)97 (35.93%)   \> 7527 (40.91%)18 (27.27%)21 (31.82%) Gender of Patient  Male35 (30.97%)37 (32.74%)41 (36.28%)0.804  Female157 (29.29%)193 (36.01%)186 (34.7%) Race  White171 (30%)202 (35.44%)197 (34.56%)0.777  Non-white21 (26.58%)28 (35.44%)30 (37.97%) Education  High school or less28 (31.82%)30 (34.09%)30 (34.09%)0.907  Some college53 (26.9%)70 (35.53%)74 (37.56%)  Completed college47 (29.94%)60 (38.22%)50 (31.85%)  Graduate school63 (30.88%)69 (33.82%)72 (35.29%)Patient health personal characteristics Health Literacy  Low13 (24.07%)19 (35.19%)22 (40.74%)0.560  High178 (30.07%)210 (35.47%)204 (34.46%) Subjective Numeracy  Low51 (31.88%)60 (37.5%)49 (30.63%)0.707  Medium61 (28.64%)77 (36.15%)75 (35.21%)  High79 (28.94%)92 (33.7%)102 (37.36%) Patient Activation Score  Level 1 (0--42.5)24 (48%)16 (32%)10 (20%)0.031  Level 2 (47.4--52.9)24 (24%)36 (36%)40 (40%)  Level 3 (56.4--66.0)92 (30.46%)99 (32.78%)111 (36.75%)  Level 4 (68.5--100)51 (26.29%)78 (40.21%)65 (33.51%) Krantz Information Scale  Low48 (29.27%)50 (30.49%)66 (40.24%)0.385  Medium67 (28.39%)87 (36.86%)82 (34.75%)  High77 (31.3%)92 (37.4%)77 (31.3%) Krantz Behavioral Scale  Low51 (27.27%)63 (33.69%)73 (39.04%)0.652  Medium61 (31.61%)69 (35.75%)63 (32.64%)  High78 (29.89%)97 (37.16%)86 (32.95%)Participant health characteristics History of Osteoporosis  Normal94 (29.38%)107 (33.44%)119 (37.19%)0.713  Osteopenia63 (30.58%)74 (35.92%)69 (33.5%)  Osteoporosis35 (28.46%)49 (39.84%)39 (31.71%) Self-rated Health  Poor5 (29.41%)5 (29.41%)7 (41.18%)0.488  Fair26 (38.24%)20 (29.41%)22 (32.35%)  Good64 (29.77%)84 (39.07%)67 (31.16%)  Very good73 (29.8%)84 (34.29%)88 (35.92%)  Excellent24 (23.08%)37 (35.58%)43 (41.35%) Number of Chronic Conditions  None86 (28.2%)112 (36.72%)107 (35.08%)0.573  1--293 (29.71%)108 (34.5%)112 (35.78%)   \> 213 (41.94%)10 (32.26%)8 (25.81%)Provider characteristics Intervention Assignment  Intervention88 (27.85%)121 (38.29%)107 (33.86%)0.323  Usual care104 (31.23%)109 (32.73%)120 (36.04%) Patient Provider's Gender  Male68 (32.69%)68 (32.69%)72 (34.62%)0.435  Female124 (28.12%)162 (36.73%)155 (35.15%) Gender of patient and provider  Female providers and female patients114 (28.64%)145 (36.43%)139 (34.92%)0.799  Female providers and male patients10 (23.26%)17 (39.53%)16 (37.21%)  Male providers and male patients25 (35.71%)20 (28.57%)25 (35.71%)  Male providers and female patients43 (31.16%)48 (34.78%)47 (34.06%)

Adjusted associations with web portal use {#Sec11}
-----------------------------------------

The multivariable logistic regression analyses (Table [3](#Tab3){ref-type="table"}) revealed that overall, web portal use was more likely for patients who were at UI (REF=KP, AOR = 1/0.39 = 2.56, *p*-value\< 0.001), younger than 75 (REF = 65--75, AOR = 1/0.67 = 1.49, *p*-value = 0.011), more educated (REF=High school graduate or less, AOR = 1.56 to 1.81, all *p*-values \< 0.002), had higher health literacy (AOR = 1.50, *p*-value = 0.014), self-reported osteopenia (REF=Normal, AOR = 1.45, *p*-value = 0.001), and were of the same gender at their provider (AOR = 1.41, *p* value =0.006). Within sites, the associations were again comparable, although *p* values were less significant due to the reduced sample sizes. The C-statistic (AUC) for our logistic regression model is 0.704, which indicates that it is a good model. Also, the p-value for Hosmer-Lemeshow test is 0.270, suggesting that there is no lack of fit. Table 3Multivariable logistic regression of patient web portal useCharacteristicAOR (95% CI)*P*-valueDemographics KP (vs. UI) Site0.39 (0.31, 0.48)\*\< 0.001 Age by category   \< 651.02 (0.83, 1.25)0.867  65--741 \[Reference\]--   ≥ 750.67 (0.49, 0.91)\*0.011 Female (vs. male) patient0.80 (0.62, 1.05)0.105 Non-White (vs. White) race0.81 (0.61, 1.08)0.146 Educational level  High school graduate or less1 \[Reference\]--  Attended college1.56 (1.18, 2.08)\*0.002  Completed college1.55 (1.14, 2.11)\*0.005  Attended graduate school1.81 (1.32, 2.47)\*\< 0.001Patient health mindset characteristics Higher health literacy1.5 (1.09, 2.07)\*0.014 Subjective numeracy  Higher numeracy1.19 (0.96, 1.49)0.114  Medium numeracy1 \[Reference\]--  Lower numeracy0.91 (0.71, 1.16)0.442 Patient Activation Score  Level 1 (0--42.5)1 \[Reference\]--  Level 2 (47.4--52.9)1.17 (0.79, 1.73)0.428  Level 3 (56.4--66.0)1.36 (0.96, 1.93)0.085  Level 4 (68.5--100)1.45 (1.00, 2.11)0.053 Information-seeking in health care  Higher level0.89 (0.72, 1.11)0.316  Medium level1 \[Reference\]--  Lower level0.79 (0.63, 1)0.054 Behavioral involvement in health care  Higher level1.23 (0.98, 1.53)0.074  Medium level1 \[Reference\]--  Lower level0.88 (0.70, 1.11)0.275Health characteristics History of Osteoporosis  Normal1 \[Reference\]--  Osteopenia1.45 (1.16, 1.81)\*0.001  Osteoporosis1.12 (0.87, 1.44)0.388 Self-rated Health  Poor0.72 (0.39, 1.31)0.278  Fair0.94 (0.68, 1.29)0.703  Good1 \[Reference\]--  Very good0.94 (0.76, 1.18)0.607  Excellent1.08 (0.80, 1.45)0.633 Number of Chronic Conditions  None1 \[Reference\]--  1--20.92 (0.76, 1.12)0.426   \> 20.70 (0.45, 1.08)0.108Provider characteristics Intervention patient0.84 (0.70, 1.00)0.054 Female Provider0.92 (0.72, 1.17)0.486 Same Gender of Patient and Provider1.41 (1.10, 1.80)\*0.006\*indicates significance of *p*=0.05 or less

Discussion {#Sec12}
==========

We used data from a large multi-site, pragmatic randomized controlled trial to examine which patients learned of their DXA results using available patient web portals. Our analysis revealed that most participants (80.9%) never used the patient web portals to view their DXA results. We also found that portal use was more common among patients who were at UI, younger than 75, more educated, had higher health literacy, self-reported osteopenia, and had a provider of the same gender.

These findings are comparable to reports from other studies that have found web portal use rates ranging from 16 to 35% \[[@CR22]--[@CR28]\]. Direct comparisons are difficult, however, because of the varying definitions of web portal use including whether patients were only registered \[[@CR22], [@CR26], [@CR28]\], or if they logged in, or if they activated their account \[[@CR23]--[@CR25], [@CR27]\]. Our study was restricted to patients who reported knowing their DXA results and said that they viewed their DXA results using the web portal. We were not, however, able to know if those who did not use the web portal to view their DXA results used the portal for other purposes.

Low rates of web portal use may be due to patients preferring other forms of communication with their providers for getting their test results. While web portals are strongly endorsed \[[@CR1]\], patients may not like them \[[@CR29]\]. A study of patient preferences for DXA result notification found that 18% of the patients considered it unacceptable to provide either normal or abnormal DXA results over a secure web portal \[[@CR29]\]. Perhaps when patients become more familiar with web portals, their acceptance of web portal notification of test results will increase. Learning more about patient's perceptions of web portals may also lead to increased use, especially among older adults.

We found that after adjusting for other factors, patients \> 75 years old had 67% lower odds of using the web portal to view their DXA results. This is consistent with most prior studies of web portal use \[[@CR22]\], although Krist et al. reported an anomalous finding that patients 60--69 years old were more likely to use the web portal than patients 18--59 or 70 years old or older \[[@CR24]\]. It has been suggested that older patients actually may be more engaged to use a web portal if they have more chronic diseases, office visits, and diagnostic tests to be informed about \[[@CR24], [@CR30], [@CR31]\]. For example, Ancker et al. did find that those with chronic conditions were more likely to register for a patient web portal \[[@CR22]\]. While we did not find a significant difference in web portal use based on the number of patient comorbidities, we did find that those who self-reported osteopenia had 45% higher odds of viewing their DXA via their web portal results than those with normal bone density. Patients with a history of osteopenia may be more anxious and thus more motivated to get their DXA results.

Unlike other studies \[[@CR22]--[@CR24], [@CR26]--[@CR28]\], we did not find that race or sex differed between web portal users and non-users. This may be due to the low number of non-Whites, especially at UI, and to having men included in our sample given that osteoporosis is general associated with White females. One of our most interesting findings was that patients with the same gender as their provider had 41% greater odds of using the web portal than those with a provider of a different gender. To our knowledge, only one other study has examined clinician characteristics related to patient web portal use, and they also found that patients with female clinicians were 37% more likely to use a web portal \[[@CR24]\]. Others have shown that women are more likely to be earlier adopters of web portals than men \[[@CR22]--[@CR24]\], and clinician adoption of web portals may stimulate patient use \[[@CR24]\].

Consistent with other studies \[[@CR12], [@CR26], [@CR32]\], we found that more educated patients had between 56 and 81% greater odds and those with higher health literacy had 50% greater odds of using the web portal to view their DXA results than those with lower education and health literacy. We expected this finding because activating, accessing, and navigating a web portal requires patients to read health-related terms. If web portals are to be emphasized and encouraged going forward, developers should keep in mind health literacy when designing web portal interfaces and how test results are communicated to patients.

Finally, there are factors that limit the generalizability of our findings. First, we included 50--64 year olds even though DXA is generally performed on older adults. In a sensitivity analysis restricted to patients \> 65 years old (data not shown), however, the associations reported here were comparable although statistical significance may not have been achieved given the reduced statistical power. Second, we relied on patient-reports of how they learned about their DXA results. Due to IRB constraints and time limitations of the two sites' information technology staff, we were unable to confirm the validity of those patient reports. Third, those who received the intervention DXA result letter may not have accessed their information via a portal because they already received their results. However, we waited four weeks after the participant had their DXA before mailing the result letter to see if they would to allow time for them to attempt to get their results in another manner. Lastly, because we could not determine the number of participants who had activated web portal accounts, the rate of those who did access their DXA results (13.9%) may have been higher if we looked at only those with activated accounts. However, those who did not have an activated account are still considered non-users of web portals and as such did not view their DXA results on the web portal.

Patient web portals offer an efficient and quick vehicle through which clinicians can communicate with patients, and for patients to be more actively involved in their health care. Determining which patients use web portals to view their DXA results is an important step in encouraging web portal use for health communication. We found that older patients and those with less education or lower health literacy or lower levels of patient activation were less likely to use the web portal. Future research should examine the barriers and facilitators for patients accessing web portals and determine their preferences for receiving their DXA results.
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